Current therapeutic approaches for Alzheimer’s disease (AD) demonstrate limited efficacy and fail to address disease progression. In the present study, we present HSN-G1, a novel ginsenoside-enriched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results